These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2552 related articles for article (PubMed ID: 25517615)

  • 21. cGAS/STING/TBK1/IRF3 Signaling Pathway Activates BMDCs Maturation Following
    Li Q; Liu C; Yue R; El-Ashram S; Wang J; He X; Zhao D; Zhou X; Xu L
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The GRA15 protein from
    Wang P; Li S; Zhao Y; Zhang B; Li Y; Liu S; Du H; Cao L; Ou M; Ye X; Li P; Gao X; Wang P; Jing C; Shao F; Yang G; You F
    J Biol Chem; 2019 Nov; 294(45):16494-16508. PubMed ID: 31416833
    [No Abstract]   [Full Text] [Related]  

  • 23. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.
    Burnette BC; Liang H; Lee Y; Chlewicki L; Khodarev NN; Weichselbaum RR; Fu YX; Auh SL
    Cancer Res; 2011 Apr; 71(7):2488-96. PubMed ID: 21300764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.
    Li T; Cheng H; Yuan H; Xu Q; Shu C; Zhang Y; Xu P; Tan J; Rui Y; Li P; Tan X
    Sci Rep; 2016 Jan; 6():19049. PubMed ID: 26754564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice.
    Lai J; Fu Y; Tian S; Huang S; Luo X; Lin L; Zhang X; Wang H; Lin Z; Zhao H; Lin S; Zhao J; Xu S; Li D; Cai S; Dong L; Qian J; Liang J; Li Q; Zhang Y; Fan J; Balderas R; Chen Q
    Mol Ther; 2021 May; 29(5):1758-1771. PubMed ID: 33571681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses.
    Huang L; Li L; Lemos H; Chandler PR; Pacholczyk G; Baban B; Barber GN; Hayakawa Y; McGaha TL; Ravishankar B; Munn DH; Mellor AL
    J Immunol; 2013 Oct; 191(7):3509-13. PubMed ID: 23986532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines.
    Suschak JJ; Wang S; Fitzgerald KA; Lu S
    J Immunol; 2016 Jan; 196(1):310-6. PubMed ID: 26590319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity.
    McAndrews KM; Che SPY; LeBleu VS; Kalluri R
    J Biol Chem; 2021; 296():100523. PubMed ID: 33711340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
    Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STING-associated lung disease in mice relies on T cells but not type I interferon.
    Luksch H; Stinson WA; Platt DJ; Qian W; Kalugotla G; Miner CA; Bennion BG; Gerbaulet A; Rösen-Wolff A; Miner JJ
    J Allergy Clin Immunol; 2019 Jul; 144(1):254-266.e8. PubMed ID: 30772497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.
    Mohamed E; Sierra RA; Trillo-Tinoco J; Cao Y; Innamarato P; Payne KK; de Mingo Pulido A; Mandula J; Zhang S; Thevenot P; Biswas S; Abdalla SK; Costich TL; Hänggi K; Anadon CM; Flores ER; Haura EB; Mehrotra S; Pilon-Thomas S; Ruffell B; Munn DH; Cubillos-Ruiz JR; Conejo-Garcia JR; Rodriguez PC
    Immunity; 2020 Apr; 52(4):668-682.e7. PubMed ID: 32294407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
    Temizoz B; Kuroda E; Ohata K; Jounai N; Ozasa K; Kobiyama K; Aoshi T; Ishii KJ
    Eur J Immunol; 2015 Apr; 45(4):1159-69. PubMed ID: 25529558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA-Mediated Cyclic GMP-AMP Synthase-Dependent and -Independent Regulation of Innate Immune Responses.
    Motani K; Ito S; Nagata S
    J Immunol; 2015 May; 194(10):4914-23. PubMed ID: 25855353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposing roles of Toll-like receptor and cytosolic DNA-STING signaling pathways for Staphylococcus aureus cutaneous host defense.
    Scumpia PO; Botten GA; Norman JS; Kelly-Scumpia KM; Spreafico R; Ruccia AR; Purbey PK; Thomas BJ; Modlin RL; Smale ST
    PLoS Pathog; 2017 Jul; 13(7):e1006496. PubMed ID: 28704551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
    Berthelot JM; Lioté F; Maugars Y; Sibilia J
    Front Immunol; 2020; 11():607069. PubMed ID: 33335532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
    Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
    Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.
    Lim J; Rodriguez R; Williams K; Silva J; Gutierrez AG; Tyler P; Baharom F; Sun T; Lin E; Martin S; Kayser BD; Johnston RJ; Mellman I; Delamarre L; West NR; Müller S; Qu Y; Heger K
    Cancer Immunol Res; 2024 Jun; 12(6):663-672. PubMed ID: 38489753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells.
    Miao L; Qi J; Zhao Q; Wu QN; Wei DL; Wei XL; Liu J; Chen J; Zeng ZL; Ju HQ; Luo HY; Xu RH
    Theranostics; 2020; 10(2):498-515. PubMed ID: 31903134
    [No Abstract]   [Full Text] [Related]  

  • 39. cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors.
    Li G; Zhao X; Zheng Z; Zhang H; Wu Y; Shen Y; Chen Q
    Cell Mol Life Sci; 2024 Mar; 81(1):149. PubMed ID: 38512518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity.
    Schadt L; Sparano C; Schweiger NA; Silina K; Cecconi V; Lucchiari G; Yagita H; Guggisberg E; Saba S; Nascakova Z; Barchet W; van den Broek M
    Cell Rep; 2019 Oct; 29(5):1236-1248.e7. PubMed ID: 31665636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 128.